Cardiovascular Diseases

Intensive BP Control Benefits T2D Patients

A Chinese parallel design, randomized clinical trial showed that the incidence of major cardiovascular events among patients with type 2 diabetes (T2D) was significantly lower with intensive treatment targeting a systolic blood pressure (SBP) of less than 120 mm Hg than with standard treatment targeting a SBP of less than 140 mm Hg. A total of 12,821 T2D patients 50 years of age or older (mean age 63.8 years, 45.3% women; 6414 patients in the intensive-treatment group and 6407 in the standard-treatment group) were enrolled from February 2019 through December 2021. At 1 year of follow-up, the mean SBP was 121.6 (median, 118.3) mm Hg in the intensive-treatment group and 133.2 (median, 135.0) mm Hg in the standard-treatment group. During a median follow-up of 4.2 years, primary-outcome events (a composite of nonfatal stroke, nonfatal myocardial infarction, treatment or hospitalization for heart failure, or death from cardiovascular causes) occurred in 393 patients (1.65 events per 100 person-years) in the intensive-treatment group and 492 patients (2.09 events per 100 person-years) in the standard-treatment group (hazard ratio, 0.79). Fatal or nonfatal stroke, the most common type of cardiovascular disease among Chinese, occurred in 284 patients (1.19 events per 100 person-years) in the intensive-treatment group and in 356 patients (1.50 events per 100 person-years) in the standard-treatment group (hazard ratio, 0.79). The benefits of intensive BP control were consistent across all prespecified subgroups. The incidence of serious adverse events was similar in the groups. However, symptomatic hypotension and hyperkalemia occurred more frequently in the intensive-treatment group than in the standard-treatment group. The finding is consistent with some other trials and provides convincing evidence of the benefits of lowering SBP to a target of less than 120 mm Hg in T2D patients. The benefits of lowering SBP to a target of less than 120 mm Hg is known in patients without diabetes. Source: https://www.nejm.org/

hyangiu

Recent Posts

Circadian Depression Subtype Linked to More Severe Symptoms and Poorer Antidepressant Response

A circadian subtype of depression is associated with earlier disease onset, more severe clinical features,…

4 days ago

Frequent and Unintentional Daytime Napping Linked to Higher Dementia Risk

A longitudinal study of 995 U.S. older adults found that frequent and unintentional daytime napping…

5 days ago

A Common CD36 Variant of Dilated Cardiomyopathy in Individuals of African Ancestry

A multicohort genetic association study found that the ancestry-enriched CD36 Y325* variant accounted for a…

5 days ago

Exercise Prescription: A Core Component of CVD Prevention and Treatment

An American College of Cardiology scientific statement emphasizes that exercise should be prescribed as a…

5 days ago

Low-Fat Vegan Diet Improves Metabolic Health in T2D

A 16-week low-fat vegan diet was associated with significant reductions in body weight, visceral fat,…

2 weeks ago

Intensive BP Lowering Reduced Cardiovascular Risk but Increased eGFR Decline

A systematic review and meta-analysis of 27 studies involving 88,830 participants found that intensive blood…

2 weeks ago

This website uses cookies.